Cerebrospinal Fluid Management Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Cerebrospinal Fluid Management Market is Segmented by Products (Shunts and External Ventricular Drainage Systems) and Geography

Cerebrospinal Fluid Management Market Snapshot

cerebrospinal fluid management devices market trends
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 4.4 %
cerebrospinal fluid management market major players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The cerebrospinal fluid management market is primarily driven by the growing hydrocephalus worldwide and the growing geriatric population. According to National Hydrocephalus Foundation, facts about hydrocephalus 2018, hydrocephalus is one of the most common birth defects and each year, one out of the 500 children suffers from hydrocephalus, and another 6000 children annually develop hydrocephalus during the first two years of the life. Moreover, the rate of hydrocephalus is also high in the older population. The growing burden of neurological disorders around the world is anticipated to boost the market growth. Moreover, the increasing R&D in advancements of device technologies coupled with the product launches are fueling the market growth. However, lack of awareness, the dearth of skilled professionals and recent warning letters from the FDA are anticipated to hinder the market growth.

Scope of the Report

Hydrocephalus defined as the presence of an excess amount of the cerebrospinal fluid in the head as a result of low absorption, disturbance of formation and flow. As per the scope of the report, cerebrospinal fluid management involves the use of medical devices such as shunts and external fluid drainage systems to drain excess fluid from the brain.

By Products
By Valve
Adjustable Valve Shunts
Monopressure Valve Shunts
By Type
Ventriculoperitoneal (VP) Shunts
Ventriculoatrial (VA) Shunts
Lumboperitoneal (LP) Shunts
Ventriculopleural (VPL) Shunts
ExternaL Vascular Drainage Devices
By Geography
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Shunts are Expected to Have Significant Market Growth

These shunt systems remove excess cerebrospinal fluid from the brain to other parts of the body where the fluid is absorbed as part of the circulatory process. Cerebrospinal fluid shunts contain three main components i.e. an in-flow tube (catheter), a valve that regulates the flow of fluid, and an outflow catheter that carries the fluid to the abdomen or the heart where the fluid can be absorbed.

The advantages of shunts over the traditional drainage procedures coupled with the advancements in cerebrospinal shunt technologies are anticipated to boost the segment growth over the forecast period. In November 2017, Alcyone Lifesciences has received U.S. Food and Drug Administration approval for Alivio Ventricular Catheter & Flusher System (Alivio System) for the treatment of hydrocephalus.

Moreover, among the patient types, the geriatric segment anticipated having the notable market growth owing to the increasing burden of neurological disorders with an aging population.

cerebrospinal fluid management devices market growth

North America is Anticipated to Have Significant Growth

Among the regions, North America is anticipated to grow at significant rates owing to the well-established healthcare infrastructure, growing awareness regarding the available options for treatment of hydrocephalus and the presence of key market players in the region. Hydrocephalus Association has estimated that around 1 million Americans are affected by hydrocephalus in every stage of life. Also, one out of the 770 babies in America, develops hydrocephalus. Moreover, Asia Pacific is anticipated to have the lucrative market growth owing to the growing awareness regarding the neurological disease and treatment options coupled with the growing burden of hydrocephalus in the region.

cerebrospinal fluid management market analysis

Competitive Landscape

The global cerebrospinal fluid management market is moderately competitive. Market players are focusing on new product launches, product innovations and geographical expansion to strengthen its market share. For instance, Arkis BioSciences Inc. has received FDA approval for its External Ventricular Drainage (EVD) Catheter, CerebroFlo, the first neuro catheter to incorporate Endexo, a permanent polymer additive. The key market players operating in the market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences (Arkis BioSciences),

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Hydrocephalus and Other Neurological Disorders

      2. 4.2.2 Growing Adoption of Minimally Invasive Solutions and Rising Geriatric Population

    3. 4.3 Market Restraints

      1. 4.3.1 Dearth of Skilled Professionals

      2. 4.3.2 Complications Related to Cerebrospinal Fluid Management Systems

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Products

      1. 5.1.1 Shunts

        1. By Valve

          1. Adjustable Valve Shunts

          2. Monopressure Valve Shunts

        2. By Type

          1. Ventriculoperitoneal (VP) Shunts

          2. Ventriculoatrial (VA) Shunts

          3. Lumboperitoneal (LP) Shunts

          4. Ventriculopleural (VPL) Shunts

      2. 5.1.2 ExternaL Vascular Drainage Devices

    2. 5.2 By Geography

      1. 5.2.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.2.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.2.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.2.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.2.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic Plc

      2. 6.1.2 B. Braun Melsungen AG

      3. 6.1.3 Integra Lifesciences (Arkis BioSciences)

      4. 6.1.4 Natus Medical Incorporated

      5. 6.1.5 Sophysa

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Spiegelberg GmbH & Co. KG

      8. 6.1.8 Moeller Medica

    2. *List Not Exhaustive

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Cerebrospinal Fluid Management Market market is studied from 2018 - 2026.

The Cerebrospinal Fluid Management Market is growing at a CAGR of 4.4% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic Plc , B. Braun Melsungen AG, Integra Lifesciences (Arkis BioSciences), Natus Medical Incorporated , Sophysa are the major companies operating in Cerebrospinal Fluid Management Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!